// App-Quantinova.ai

464 : Long-term safety and maintenance of analgesia with an extended-release hydrocodone tablet formulated with OraGuard technology during a 12-month open-label study in patients with chronic pain

Researchers

Presenter

  • M. Hale

Principal Investigators

  • T. Zimmerman Jr

  • Y. ma

  • R. Malamut

Medical Centers

  • Gold Coast Research, L.L.C., Plantation, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Deep vein thrombosis

  • Cardiac arrest

  • Renal insufficiency

  • Chronic pain

  • Constipation

  • Hyperkalemia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • hydrocodone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved